Companies included in IBRN
This is IBRN's own dated portfolio constitution. Share counts are the calculation basis for constituent revenue and earnings analytics; rounded weights are reference values only. This page shows positions 1–84 of 84.
| Ticker | Issuer | Shares owned | Unit | Reported weight |
|---|---|---|---|---|
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 443,377.6968 | NS | 8.571276% |
| XENE | Xenon Pharmaceuticals Inc | 4,419 | NS | 4.785899% |
| AXSM | AXSOME THERAPEUTICS, INC. | 1,144 | NS | 4.593127% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 3,103 | NS | 4.406485% |
| ALKERMES PUBLIC LIMITED COMPANY | ALKERMES PUBLIC LIMITED COMPANY | 6,446 | NS | 4.199431% |
| CENTESSA PHARMACEUTICALS PLC | CENTESSA PHARMACEUTICALS PLC | 5,186 | NS | 3.95085% |
| ARGX | argenx SE | 257 | NS | 3.882627% |
| PTCT | PTC THERAPEUTICS, INC. | 2,938 | NS | 3.694088% |
| NBIX | NEUROCRINE BIOSCIENCES, INC. | 1,448 | NS | 3.684654% |
| BIIB | BIOGEN INC. | 1,004 | NS | 3.672652% |
| SRRK | Scholar Rock Holding Corp | 4,075 | NS | 3.670693% |
| PRAX | Praxis Precision Medicines Inc | 594 | NS | 3.66005% |
| ACAD | ACADIA PHARMACEUTICALS INC. | 8,328 | NS | 3.613253% |
| DNTH | Dianthus Therapeutics Inc | 1,998 | NS | 3.390247% |
| CATALYST PHARMACEUTICALS, INC. | CATALYST PHARMACEUTICALS, INC. | 6,048 | NS | 3.287932% |
| DNLI | Denali Therapeutics Inc | 7,800 | NS | 2.821901% |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | 3,000 | NS | 2.78294% |
| EWTX | Edgewise Therapeutics Inc | 4,232 | NS | 2.532141% |
| DYN | Dyne Therapeutics, Inc | 6,966 | NS | 2.362664% |
| AXGN | AxoGen, Inc. | 2,800 | NS | 2.33767% |
| SRPT | SAREPTA THERAPEUTICS, INC. | 5,480 | NS | 2.211324% |
| SK Biopharmaceuticals Co Ltd | SK Biopharmaceuticals Co Ltd | 1,547 | NS | 2.041476% |
| H. LUNDBECK A/S | H. LUNDBECK A/S | 14,762 | NS | 1.917891% |
| CAPR | Capricor Therapeutics Inc | 2,693 | NS | 1.747666% |
| TSHA | Taysha Gene Therapies Inc | 12,369 | NS | 1.527484% |
| BioArctic AB | BioArctic AB | 2,026 | NS | 1.373177% |
| BHVN | Biohaven Ltd | 7,016 | NS | 1.300318% |
| Neuren Pharmaceuticals Ltd | Neuren Pharmaceuticals Ltd | 6,016 | NS | 1.057162% |
| RAPP | Rapport Therapeutics Inc | 1,610 | NS | 1.030834% |
| Dynavox Group AB | Dynavox Group AB | 5,451 | NS | 0.936273% |
| DRUG | Bright Minds Biosciences Inc | 539 | NS | 0.916149% |
| Idorsia Ltd | Idorsia Ltd | 9,565 | NS | 0.871566% |
| ANNX | Annexon Inc | 7,048 | NS | 0.799549% |
| ANRO | Alto Neuroscience Inc | 1,571 | NS | 0.779066% |
| SanBio Company Limited | SanBio Company Limited | 3,200 | NS | 0.750663% |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORPORATION | 3,675 | NS | 0.748582% |
| Medincell SA | Medincell SA | 1,155 | NS | 0.646557% |
| LBRX | LB Pharmaceuticals Inc | 1,036 | NS | 0.634888% |
| Brainsway Ltd | Brainsway Ltd | 1,869 | NS | 0.598151% |
| CBLL | Ceribell Inc | 1,337 | NS | 0.520911% |
| Prothena Corporation PLC | Prothena Corporation PLC | 2,392 | NS | 0.511279% |
| Zylox-Tonbridge Medical Technology Co Ltd | Zylox-Tonbridge Medical Technology Co Ltd | 9,000 | NS | 0.509421% |
| Oncolys Biopharma Inc | Oncolys Biopharma Inc | 1,400 | NS | 0.490917% |
| RLMD | Relmada Therapeutics Inc | 3,334 | NS | 0.484535% |
| SLDB | Solid Biosciences Inc | 3,302 | NS | 0.463292% |
| MicroPort NeuroScientific Corp | MicroPort NeuroScientific Corp | 18,000 | NS | 0.463139% |
| DSGN | Design Therapeutics Inc | 1,744 | NS | 0.458381% |
| NPCE | Neuropace Inc | 1,398 | NS | 0.455519% |
| RGNX | Regenxbio Inc | 2,532 | NS | 0.438932% |
| BNTC | Benitec Biopharma Inc | 1,798 | NS | 0.418715% |
| MPLT | MapLight Therapeutics Inc | 677 | NS | 0.416977% |
| VNDA | VANDA PHARMACEUTICALS INC. | 2,996 | NS | 0.411094% |
| PEIJIA MEDICAL LIMITED | PEIJIA MEDICAL LIMITED | 26,000 | NS | 0.399643% |
| Newron Pharmaceuticals SpA | Newron Pharmaceuticals SpA | 991 | NS | 0.350514% |
| NGNE | NEUROGENE INC. | 678 | NS | 0.341858% |
| OVID | OVID THERAPEUTICS INC. | 6,364 | NS | 0.340684% |
| AVXL | Anavex Life Sciences Corp | 4,943 | NS | 0.319064% |
| TRDA | Entrada Therapeutics Inc | 1,178 | NS | 0.307341% |
| CLPT | Clearpoint Neuro Inc | 1,418 | NS | 0.306379% |
| Santhera Pharmaceuticals Holding AG | Santhera Pharmaceuticals Holding AG | 656 | NS | 0.276182% |
| ACIU | AC Immune SA | 3,350 | NS | 0.196168% |
| ALEC | Alector Inc | 4,108 | NS | 0.188157% |
| IKT | Inhibikase Therapeutics Inc | 5,080 | NS | 0.185553% |
| VYGR | Voyager Therapeutics Inc | 2,514 | NS | 0.181224% |
| LRMR | Larimar Therapeutics Inc | 2,281 | NS | 0.178975% |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | 688 | NS | 0.171921% |
| Myung In Pharm Co Ltd | Myung In Pharm Co Ltd | 211 | NS | 0.155393% |
| NMRA | Neumora Therapeutics Inc | 3,060 | NS | 0.14607% |
| ABOS | Acumen Pharmaceuticals Inc | 2,555 | NS | 0.118013% |
| PEPG | PepGen Inc | 3,356 | NS | 0.106367% |
| CGTX | Cognition Therapeutics Inc | 4,343 | NS | 0.105755% |
| BrainAurora Medical Technology Ltd | BrainAurora Medical Technology Ltd | 10,000 | NS | 0.093515% |
| GANX | Gain Therapeutics Inc | 2,048 | NS | 0.074805% |
| FLNA | Filana Therapeutics, Inc | 2,457 | NS | 0.068852% |
| SGMOQ | SANGAMO THERAPEUTICS, INC. | 21,725 | NS | 0.050047% |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 2,445.3 | NS | 0.047258% |
| AUSTRALIAN DOLLAR | AUSTRALIAN DOLLAR | 1,400.44 | NS | 0.019485% |
| JAPANESE YEN | JAPANESE YEN | 138,196 | NS | 0.01706% |
| SWISS FRANC | SWISS FRANC | 220.01 | NS | 0.005442% |
| SWEDISH KRONE | SWEDISH KRONE | 1,764.06 | NS | 0.003693% |
| KOREAN WON | KOREAN WON | 191,328 | NS | 0.002493% |
| HONG KONG DOLLAR | HONG KONG DOLLAR | 772.38 | NS | 0.001906% |
| EURO | EURO | 63.62 | NS | 0.001443% |
| DANISH KRONER | DANISH KRONER | 444.81 | NS | 0.00135% |
SEC N-PORT snapshot as of .